Management of Stage III Non–Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update

Author:

Daly Megan E.1,Singh Navneet2ORCID,Ismaila Nofisat3ORCID, ,Daly Megan E.,Singh Navneet,Ismaila Nofisat,Antonoff Mara B.,Arenberg Douglas A.,Bradley Jeffrey,David Elizabeth,Detterbeck Frank,Früh Martin,Gubens Matthew A.,Moore Amy C.,Padda Sukhmani K.,Patel Jyoti D.,Phillips Tanyanika,Qin Angel,Robinson Clifford,Simone Charles B.

Affiliation:

1. University of California Davis Comprehensive Cancer Center, Sacramento, CA

2. Postgraduate Institute of Medical Education & Research, Chandigarh, India

3. American Society of Clinical Oncology, Alexandria, VA

Abstract

ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating provider and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only).

Publisher

American Society of Clinical Oncology (ASCO)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3